Osteobiologics Market to Grow with a CAGR of 3.20% through 2028
Surgical advancements and continuous research and
development efforts are expected to drive the Global Osteobiologics Market
growth in the forecast period, 2024-2028.
According to TechSci Research report, “Osteobiologics
Market – Global Industry Size, Share, Trends, Competition Forecast &
Opportunities, 2028”, the Global Osteobiologics Market stood at USD 19.58
billion in 2022 and is anticipated to grow with a CAGR of 3.20% in the forecast
period, 2024-2028. This can be attributed to surgical advancements. The
development of minimally invasive surgical techniques has expanded the use of
osteobiologics. These techniques reduce trauma to surrounding tissues and
improve the effectiveness of osteobiologic products. As surgeons become more
skilled in utilizing these techniques, the market for osteobiologics continues
to grow.
Furthermore, the use of osteobiologics is extending
beyond orthopedic and spinal surgeries. Dentistry, maxillofacial surgery, and
other medical specialties are now recognizing the benefits of these products in
promoting bone healing and regeneration. This expansion into new applications
is broadening the market's scope.
Browse over XX market data Figures spread
through XX Pages and an in-depth TOC on "Global Osteobiologics
Market.”
The global osteobiologics market refers to a rapidly
growing sector within the medical industry that specializes in the development
and distribution of biological products and materials designed to enhance bone
healing and regeneration. These products are commonly used in orthopedic and
spinal surgical procedures to facilitate bone growth, repair, and fusion.
The Global Osteobiologics Market is segmented into
product, application, end user, regional distribution, and company.
Based on its product, the Plasma-Rich Protein (PRP) is
poised to capture a substantial market share in the Global Osteobiologics
Market during the forecast period for several compelling reasons. Firstly, PRP
offers a minimally invasive and cost-effective alternative for promoting bone
healing and tissue regeneration, making it an attractive choice for both
patients and healthcare providers. Moreover, its proven efficacy in enhancing
the body's natural healing processes and reducing recovery times positions PRP
as a preferred option in orthopedic and dental surgeries, which are on the rise
globally. Additionally, the increasing awareness of the benefits of PRP in
accelerating healing and reducing complications, along with its versatility in
various applications, including sports medicine and aesthetics, further cements
its dominance in the Osteobiologics market. As a result, PRP is set to become a
frontrunner in this market, fostering growth and innovation in the
orthobiologics sector.
Based on application, the Maxillofacial and Dental
Applications segment is poised to secure a substantial market share during the
forecast period in the Global Osteobiologics Market for a multitude of
compelling reasons. First and foremost, the rising prevalence of dental and maxillofacial
conditions, coupled with an aging global population, underscores the growing
demand for advanced solutions in this sector. Osteobiologics offer a range of
innovative and effective treatment options for these specific applications,
such as bone grafts and growth factors, significantly enhancing patient
outcomes and reducing recovery times. Furthermore, ongoing technological
advancements and the increasing adoption of minimally invasive procedures have
fueled the attractiveness of osteobiologics in this niche, as they provide
safer and more efficient alternatives to traditional treatments. With growing
awareness among both healthcare professionals and patients regarding the
advantages of osteobiologics in maxillofacial and dental applications, this
segment is poised to be a significant driver of growth in the Global
Osteobiologics Market, making it a key area of focus for industry stakeholders.
Major companies operating in Global Osteobiologics
Market are:
- Stryker Corp
- DePuy Synthes Inc
- Medtronic PLC
- Osteomed LP
- Zimmer Biomet Holdings, Inc.
- Smith & Nephew plc
- Genzyme Corp
- Arthrex Inc
- Orthofix International BV
Download
Free Sample Report
Customers can also request for 10%
free customization on this report.
“The global osteobiologics market is in a state of
exciting transformation. Emerging trends are redefining the landscape by
offering more personalized treatments, advanced biomaterials, minimally
invasive techniques, and expanded applications. As the market continues to
evolve, it's essential for healthcare professionals, manufacturers, and
regulators to collaborate and adapt to these trends to ensure that patients
benefit from the latest advancements in osteobiologics and that the industry
continues to thrive. The future of the osteobiologics market holds great
promise for patients and the broader field of regenerative medicine,” said Mr.
Karan Chechi, Research Director with TechSci Research, a research-based
management consulting firm.
“Osteobiologics Market By
Product (Allografts, Bone Marrow Aspirate
Concentrate, Bone Morphogenic Protein, Demineralized Bone Matrices, Plasma-Rich
Protein, Synthetic Orthobiologics, Visco-Supplementation Products), By
Application (Fracture Recovery, Maxillofacial & Dental Applications,
Osteoarthritis & Degenerative Arthritis, Soft-Tissue Injuries, Spinal
Fusion), By End User (Dental Clinics & Facilities, Hospitals, Research
& Academic Institutes, Specialty Clinics, Others), By Region, By Competition Forecast &
Opportunities, 2018-2028F”, has evaluated the future growth potential of Global
Osteobiologics Market and provides statistics & information on market size,
structure and future market growth. The report intends to provide cutting-edge
market intelligence and help decision makers take sound investment decisions.
Besides, the report also identifies and analyzes the emerging trends along with
essential drivers, challenges, and opportunities in Global Osteobiologics Market.
Contact
Techsci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com